SG52393G - Therapeutic agent for the treatment of disorders associated with cerebral ischemia - Google Patents
Therapeutic agent for the treatment of disorders associated with cerebral ischemiaInfo
- Publication number
- SG52393G SG52393G SG52393A SG52393A SG52393G SG 52393 G SG52393 G SG 52393G SG 52393 A SG52393 A SG 52393A SG 52393 A SG52393 A SG 52393A SG 52393 G SG52393 G SG 52393G
- Authority
- SG
- Singapore
- Prior art keywords
- treatment
- therapeutic agent
- disorders associated
- cerebral ischemia
- ischemia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19879686 | 1986-08-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG52393G true SG52393G (en) | 1993-08-06 |
Family
ID=16397046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG52393A SG52393G (en) | 1986-08-27 | 1993-04-23 | Therapeutic agent for the treatment of disorders associated with cerebral ischemia |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4870090A (es) |
| JP (1) | JPH07121863B2 (es) |
| KR (1) | KR950002151B1 (es) |
| AU (1) | AU603375B2 (es) |
| BE (1) | BE1003959A5 (es) |
| CA (1) | CA1302888C (es) |
| CH (1) | CH672069A5 (es) |
| DE (1) | DE3728499A1 (es) |
| DK (1) | DK171392B1 (es) |
| FI (1) | FI873727A (es) |
| FR (1) | FR2605222B1 (es) |
| GB (1) | GB2195532B (es) |
| HK (1) | HK64993A (es) |
| IE (1) | IE60601B1 (es) |
| IT (1) | IT1211477B (es) |
| LU (1) | LU86973A1 (es) |
| NL (1) | NL8701994A (es) |
| NO (1) | NO873571L (es) |
| NZ (1) | NZ221564A (es) |
| SE (1) | SE502323C2 (es) |
| SG (1) | SG52393G (es) |
| ZA (1) | ZA876401B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5736529A (en) * | 1996-03-22 | 1998-04-07 | Neurocal International Inc. | Use of NAD-related compounds in the treatment of neural trauma to inhibit neurodegeneration |
| US6329349B1 (en) * | 1997-10-23 | 2001-12-11 | Trustees Of The University Of Pennsylvania | Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid A and adenosine receptor agents |
| AU4841700A (en) | 1999-05-12 | 2000-11-21 | Nitromed, Inc. | Nitrosated and nitrosylated potassium channel activators, compositions and methods of use |
| CN107773545A (zh) * | 2016-08-29 | 2018-03-09 | 烟台益诺依生物医药科技有限公司 | 依达拉奉与(+)‑2‑莰醇的舌下用药物组合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1562962A (en) * | 1976-04-02 | 1980-03-19 | Chugai Pharmaceutical Co Ltd | Nicotinamide derivatives processes for producting the same and pharmaceutical compositions containing the same |
| US4200640A (en) * | 1976-04-02 | 1980-04-29 | Chugai Seiyaku Kabushiki Kaisha | Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use |
| WO1986006960A2 (en) * | 1985-05-22 | 1986-12-04 | Beecham Group P.L.C. | Use of nicorandil or pinacidil for the treatment of peripheral vascular disease |
| US4696934A (en) * | 1986-01-10 | 1987-09-29 | Warner-Lambert Company | Method for using nifedipine for treating stroke |
| WO1987005508A1 (en) * | 1986-03-14 | 1987-09-24 | Medical College Of Wisconsin Research Foundation, | Method of treatment and prevention of cerebral vasospasms |
-
1987
- 1987-08-19 IE IE221887A patent/IE60601B1/en not_active IP Right Cessation
- 1987-08-21 IT IT8767725A patent/IT1211477B/it active
- 1987-08-21 AU AU77311/87A patent/AU603375B2/en not_active Ceased
- 1987-08-24 US US07/089,044 patent/US4870090A/en not_active Expired - Lifetime
- 1987-08-24 NO NO873571A patent/NO873571L/no unknown
- 1987-08-25 DK DK441987A patent/DK171392B1/da not_active IP Right Cessation
- 1987-08-25 NZ NZ221564A patent/NZ221564A/xx unknown
- 1987-08-26 LU LU86973A patent/LU86973A1/fr unknown
- 1987-08-26 NL NL8701994A patent/NL8701994A/nl active Search and Examination
- 1987-08-26 DE DE19873728499 patent/DE3728499A1/de not_active Withdrawn
- 1987-08-26 CA CA000545418A patent/CA1302888C/en not_active Expired - Fee Related
- 1987-08-26 SE SE8703308A patent/SE502323C2/sv not_active IP Right Cessation
- 1987-08-26 FR FR878711957A patent/FR2605222B1/fr not_active Expired - Fee Related
- 1987-08-26 BE BE8700948A patent/BE1003959A5/fr not_active IP Right Cessation
- 1987-08-26 KR KR1019870009346A patent/KR950002151B1/ko not_active IP Right Cessation
- 1987-08-27 JP JP62213808A patent/JPH07121863B2/ja not_active Expired - Fee Related
- 1987-08-27 GB GB8720219A patent/GB2195532B/en not_active Expired - Fee Related
- 1987-08-27 ZA ZA876401A patent/ZA876401B/xx unknown
- 1987-08-27 FI FI873727A patent/FI873727A/fi not_active Application Discontinuation
- 1987-08-27 CH CH3298/87A patent/CH672069A5/de not_active IP Right Cessation
-
1993
- 1993-04-23 SG SG52393A patent/SG52393G/en unknown
- 1993-07-08 HK HK649/93A patent/HK64993A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| LU86973A1 (fr) | 1987-12-16 |
| GB8720219D0 (en) | 1987-10-07 |
| NZ221564A (en) | 1999-08-30 |
| KR950002151B1 (ko) | 1995-03-14 |
| SE8703308L (sv) | 1988-02-28 |
| ZA876401B (en) | 1988-04-27 |
| NL8701994A (nl) | 1988-03-16 |
| BE1003959A5 (fr) | 1992-07-22 |
| FI873727A (fi) | 1988-02-28 |
| US4870090A (en) | 1989-09-26 |
| KR880002525A (ko) | 1988-05-09 |
| SE502323C2 (sv) | 1995-10-02 |
| GB2195532A (en) | 1988-04-13 |
| AU7731187A (en) | 1988-03-03 |
| DE3728499A1 (de) | 1988-03-03 |
| CH672069A5 (es) | 1989-10-31 |
| NO873571L (no) | 1988-02-29 |
| JPS63152317A (ja) | 1988-06-24 |
| NO873571D0 (no) | 1987-08-24 |
| FR2605222A1 (fr) | 1988-04-22 |
| GB2195532B (en) | 1990-05-23 |
| DK441987A (da) | 1988-02-28 |
| HK64993A (en) | 1993-07-16 |
| DK171392B1 (da) | 1996-10-14 |
| SE8703308D0 (sv) | 1987-08-26 |
| IT1211477B (it) | 1989-11-03 |
| IT8767725A0 (it) | 1987-08-21 |
| FI873727A0 (fi) | 1987-08-27 |
| IE60601B1 (en) | 1994-07-27 |
| DK441987D0 (da) | 1987-08-25 |
| IE872218L (en) | 1988-02-27 |
| FR2605222B1 (fr) | 1991-02-22 |
| AU603375B2 (en) | 1990-11-15 |
| CA1302888C (en) | 1992-06-09 |
| JPH07121863B2 (ja) | 1995-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG18268A (en) | Medicament for the treatment of inflammation of the eye | |
| IL83925A0 (en) | Compositions for treatment of skin disorders | |
| GB2188234B (en) | Therapeutic agents | |
| AU6747887A (en) | Treatment of skin disorders | |
| EP0331620A3 (en) | Agent for the treatment of parkinson's disease | |
| EP0275668A3 (en) | Use of ketone derivatives in the treatment of cognitive disorders | |
| EP0249873A3 (en) | Therapeutic agent for skin ulcers | |
| AU4530989A (en) | Pharmaceutical composition for the treatment of cerebral edema | |
| US4931457B1 (en) | Naphthylamino-and naphthyloxy-pyridineamin compounds useful as topical antiinflammatory agents for the treatment of skin disorders | |
| GB2195532B (en) | Therapeutic agent for the treatment of disorders associated with cerebral ischemia | |
| GB2204488B (en) | Pharmaceutical compositions for the treatment or prophylaxis of skin disorders | |
| EP0457671A3 (en) | Dipyridamide for the treatment of diseases of the central or peripheral nervous system | |
| ZA884835B (en) | Treatment of cerebral disorders | |
| ZA893606B (en) | Use of diazepinones for treating disorders of the microcirculation | |
| ZA881828B (en) | Preparation for treatment of skin disorders | |
| KR0149275B1 (en) | Medicaments for the treatment of cerebral apoplexy | |
| ZA879287B (en) | Preparation for the treatment of gastric disorders | |
| IL83633A0 (en) | Device for the treatment of the skin | |
| GB8618614D0 (en) | Treatment of psychiatric disorders | |
| GB8817446D0 (en) | Treatment of various blood disorders | |
| IE900102L (en) | Treatment of skin disorders | |
| GB8705285D0 (en) | Treatment of psychiatric disorders | |
| GB8725008D0 (en) | Treatment of psychiatric disorders | |
| GB8621781D0 (en) | Anti-aids therapeutic agents | |
| IE862064L (en) | Pharmaceutical compounds effective against eye disorders |